BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21391426)

  • 21. Direct revascularization is superior for rat parathyroid allotransplantation with FK506.
    Nelson M; Dan O; Strome M
    Ann Otol Rhinol Laryngol; 2005 Mar; 114(3):207-13. PubMed ID: 15825570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Everolimus in combination with cyclosporin a as pre- and posttransplantation immunosuppressive therapy in nonmyeloablative allogeneic hematopoietic stem cell transplantation.
    Junghanss C; Rathsack S; Wacke R; Weirich V; Vogel H; Drewelow B; Mueller S; Altmann S; Freund M; Lange S
    Biol Blood Marrow Transplant; 2012 Jul; 18(7):1061-8. PubMed ID: 22182476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Site-specific immunosuppression using a new formulation of topical cyclosporine A with polyethylene glycol-8 glyceryl caprylate/caprate.
    Tran HS; Malli D; Chrzanowski FA; Puc MM; Matthews MS; Hewitt CW
    J Surg Res; 1999 May; 83(2):136-40. PubMed ID: 10329107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Once daily everolimus is safe and effective in de novo renal transplant recipients: six-month results of a pilot study.
    Favi E; Spagnoletti G; Gargiulo A; Salerno MP; Romagnoli J; Citterio F
    Transplant Proc; 2010 May; 42(4):1308-11. PubMed ID: 20534287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic effects of CTLA-4Ig and sirolimus on orthotopic lung-allograft survival and histology.
    Ugurlu MM; Griffin MD; Tazelaar HD; McGregor CG
    Transplantation; 2003 Aug; 76(3):489-95. PubMed ID: 12923433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunomodulatory Effects of Different Cellular Therapies of Bone Marrow Origin on Chimerism Induction and Maintenance Across MHC Barriers in a Face Allotransplantation Model.
    Hivelin M; Klimczak A; Cwykiel J; Sonmez E; Nasir S; Gatherwright J; Siemionow M
    Arch Immunol Ther Exp (Warsz); 2016 Aug; 64(4):299-310. PubMed ID: 26708158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of adding steroids, in vitro irradiation, or both to cyclosporine immunosuppression in the murine laryngeal transplantation model.
    Lorenz RR; Dan O; Haug M; Strome M
    Ann Otol Rhinol Laryngol; 2002 May; 111(5 Pt 1):455-9. PubMed ID: 12019516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decoy NF-kappaB fortified immature dendritic cells maintain laryngeal allograft integrity and provide enhancement of regulatory T cells.
    Lott DG; Dan O; Lu L; Strome M
    Laryngoscope; 2010 Jan; 120(1):44-52. PubMed ID: 19877191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the novel protein kinase C inhibitor AEB071 (Sotrastaurin) on rat cardiac allograft survival using single agent treatment or combination therapy with cyclosporine, everolimus or FTY720.
    Weckbecker G; Pally C; Beerli C; Burkhart C; Wieczorek G; Metzler B; Morris RE; Wagner J; Bruns C
    Transpl Int; 2010 May; 23(5):543-52. PubMed ID: 20003043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of the early introduction of everolimus with reduced-exposure cyclosporine a in de novo kidney recipients.
    Oh CK; Huh KH; Ha J; Kim YH; Kim YL; Kim YS
    Transplantation; 2015 Jan; 99(1):180-6. PubMed ID: 24983307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of bronchiolitis obliterans in allogeneic rat lung transplantation--effectiveness of everolimus.
    von Suesskind-Schwendi M; Brunner E; Hirt SW; Diez C; Ruemmele P; Puehler T; Schmid C; Lehle K
    Exp Toxicol Pathol; 2013 May; 65(4):383-9. PubMed ID: 22284335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergism of imatinib mesylate and everolimus in attenuation of bronchiolitis obliterans after rat LTX.
    von Suesskind-Schwendi M; Valenti V; Haneya A; Pühler T; Bewig B; Schmid C; Hirt SW; Lehle K
    Histol Histopathol; 2013 Oct; 28(10):1273-84. PubMed ID: 23471704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of immunosuppression on survival of allograft limbal stem cells.
    Chen W; Cao L; Hara K; Yoshitomi T
    Jpn J Ophthalmol; 2004; 48(5):440-7. PubMed ID: 15486765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of thymus in operational tolerance induction in limb allograft transplant model.
    Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A
    Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TCR alpha/beta targeted therapy in the rat: pretreatment with R73 monoclonal antibody induces profound immunological anergy and long-term allograft survival.
    Heidecke CD; Hancock WW; Jakobs F; Westerholt S; Sewzcik T; Deusch K; Zantl N; Kurrle R; Kupiec-Weglinski J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):540-2. PubMed ID: 8438405
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of everolimus as a rescue immunosuppressive therapy in liver transplant patients with neoplasms.
    Gomez-Camarero J; Salcedo M; Rincon D; Lo Iacono O; Ripoll C; Hernando A; Sanz C; Clemente G; Bañares R
    Transplantation; 2007 Sep; 84(6):786-91. PubMed ID: 17893613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus.
    Albano L; Berthoux F; Moal MC; Rostaing L; Legendre C; Genin R; Toupance O; Moulin B; Merville P; Rerolle JP; Bayle F; Westeel PF; Glotz D; Kossari N; Lefrançois N; Charpentier B; Blanc AS; Di Giambattista F; Dantal J;
    Transplantation; 2009 Jul; 88(1):69-76. PubMed ID: 19584683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term immunosuppression after rat parathyroid allotransplantation.
    Timm S; Otto C; Begrich D; Illert B; Hamelmann W; Ulrichs K; Thiede A; Timmermann W
    Microsurgery; 2003; 23(5):503-7. PubMed ID: 14558011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic immunosuppressive actions of cyclosporine with a mouse anti-rat alpha/beta-T cell receptor monoclonal antibody.
    Knight RJ; Kurrle R; Stepkowski S; Serino F; Chou TC; Kahan BD
    Transplantation; 1994 Jun; 57(11):1544-8. PubMed ID: 8009587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategies to develop chimerism in vascularized skin allografts across MHC barrier.
    Demir Y; Ozmen S; Klimczak A; Mukherjee AL; Siemionow MZ
    Microsurgery; 2005; 25(5):415-22. PubMed ID: 16025439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.